Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autograffs using recombinant adenovirus

Cancer Gene Therapy

Volumn 3, Issue 4, 1996, Pages 257-264

  Wroblewski, Joanne M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Contaminating malignant cells; Hematopoietic stem cell autografts; Purging; Recombinant adenovirus

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; PROTEIN P53; THYMIDINE KINASE;

ADENOVIRUS; ARTICLE; CELL CULTURE; ENZYMOLOGY; GENE TRANSFER; GENETIC RECOMBINATION; GENETICS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PATHOLOGY;

ADENOVIRIDAE; ANTIVIRAL AGENTS; GANCICLOVIR; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; RECOMBINATION, GENETIC; THYMIDINE KINASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030179357     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkins lymphoma. N Engl J Med. 1995;333:1540-1545.
2. Bezwoda W, Seymour L, Dansey R. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol. 1995;13:2483-2489.